上 市 公 司 国防军工 2025 年 07 月 11 日 中国重工 (601989) ——业绩预增超预期，船价已现企稳迹象，重组事项提上 日程 报告原因：有业绩公布需要点评 投资要点： | | 2024 | 2025Q1 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 55,436 | 12,216 | 62,100 | 77,833 | 93,996 | | 同比增长率（%） | 18.7 | 20.1 | 12.0 | 25.3 | 20.8 | | 归母净利润（百万元） | 1,311 | 519 | 3,671 | 7,245 | 10,992 | | 同比增长率（%） | - | 282.0 | 180.1 | 97.4 | 51.7 | | 每股收益（元/股） | 0.06 | 0.02 | 0.16 | 0.32 | 0.48 | | 毛利率（%） | 10.8 | 12.9 | 15.0 | 17.7 | 19.7 | | ROE（%） | 1.6 | 0.6 | 4.2 | 7.8 ...

Group 1 - The company expects to achieve a net profit of approximately 180 million yuan for the first half of 2025, representing a decrease of about 226 million yuan or approximately 56% compared to the same period last year [2][2][2] - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to remain roughly the same as the previous year [2][2][2] - The primary reason for the decrease in performance is the reduction in non-recurring income compared to the previous year [2][2][2] Group 2 - In the first half of 2024, the company reported a net profit of approximately 208.68 million yuan [2][2][2] - The basic earnings per share for the first half of 2024 were 0.0962 yuan, and the basic earnings per share after deducting non-recurring gains and losses were 0.0494 yuan [2][2][2] - The decrease in net profit for the first half of 2025 is attributed to the insurance compensation recognized for the Zhongxing 6C satellite in the first half of 2024 [2][2][2]

证券代码：600156 证券简称：华升股份 公告编号：临 2025-035 湖南华升股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性 承担法律责任。 重要内容提示： ? 湖南华升股份有限公司（以下简称"公司"）预计 2025 年半年 度实现归属于母公司所有者的净利润为-1,600 万元到-1,200 万元。 ? 报告期内，归属于母公司所有者的扣除非经常性损益后的净 利润为-4,000 万元到-3,350 万元。 预计 2025 年半年度实现归属于母公司所有者的扣除非经常性损 益后的净利润为-4,000 万元到-3,350 万元。 （三）本期业绩预告为本公司初步测算，未经注册会计师审计。 二、上年同期经营业绩和财务状况 （一）归属于母公司所有者的净利润：-2,562.19 万元。归属于 母公司所有者的扣除非经常性损益的净利润：-1,484.55 万元。 （二）每股收益：-0.0637 元。 一、本期业绩预告情况 （一）业绩预告期间 （二）业绩预告情况 经财务部门初步测算，预计 2025 年半年度实现归属于母公司所 有者的净利润为- ...

本次业绩预告是公司财务部门的初步测算结果，未经会计师事务所审核，具 体财务数据将在公司 2025 年半年度报告中予以详细披露。敬请广大投资者谨慎 决策投资，注意投资风险。 证券代码：000893 证券简称：亚钾国际 公告编号：2025-034 亚钾国际投资（广州）股份有限公司 本公司及董事会全体成员（除董事长郭柏春先生，被实施留置）保证信息披 露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 项 目 本报告期 上年同期 盈利：73,000 万元-93,000 万元 归属于上市公司股 盈利：26,998.79 万元 东的净利润 比上年同期增长：170%-244% 归属于上市公司股 盈利：73,000 万元-93,000 万元 东的扣除非经常性 盈利：26,795.76 万元 损益的净利润 比上年同期增长：172%-247% 基本每股收益 盈利：0.80 元/股–1.02 元/股 盈利：0.29 元/股 二、与会计师事务所沟通情况 本次业绩预告未经会计师事务所审计。 三、业绩变动原因说明 报告期内，公司经营业绩同比上升，主要原因如下：一是公司钾肥生产线稳 定生产，上半年钾肥产量 ...

Core Viewpoint - Shenzhen Airport (000089) expects a significant increase in net profit for the first half of 2025, driven by rising demand in the civil aviation market and steady growth in passenger and cargo operations [1] Financial Performance - The net profit attributable to shareholders is projected to be between 287 million yuan and 337 million yuan, representing a year-on-year growth of 64.78% to 93.47% compared to 174 million yuan in the same period last year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 236 million yuan and 286 million yuan, marking a year-on-year increase of 93.79% to 134.85% from 122 million yuan [1] - Basic earnings per share are anticipated to be between 0.14 yuan and 0.1644 yuan, compared to 0.085 yuan in the same period last year [1] Operational Metrics - Passenger throughput is expected to increase by 10.9% year-on-year [1] - The number of flight takeoffs and landings is projected to rise by 7.2% year-on-year [1] - Cargo and mail throughput is anticipated to grow by 14.1% year-on-year [1]

Core Viewpoint - Jin控电力 (000767) expects a significant turnaround in net profit for the period from January 1, 2025, to June 30, 2025, projecting a profit of 120 million to 150 million yuan, compared to a loss of 376 million yuan in the same period last year, indicating a year-on-year increase of 131.91% to 139.89% [1] Financial Performance - The net profit attributable to shareholders is projected to be between 120 million and 150 million yuan, a substantial improvement from the previous year's loss of 376 million yuan [1] - The net profit after deducting non-recurring gains and losses is expected to be between 126 million and 159 million yuan, compared to a loss of 381 million yuan in the same period last year, reflecting an increase of 133.17% to 141.83% year-on-year [1] - The basic earnings per share is anticipated to range from a loss of 0.0055 yuan per share to a profit of 0.0043 yuan per share [1]

Core Viewpoint - Jineng Technology (603113.SH) expects a significant increase in net profit for the first half of 2025, projecting a growth of 155.77% to 165.07% year-on-year, driven by increased sales volume and revenue of main products, improved gross margins of olefins and coke, reduced financial expenses, and increased investment income [1] Summary by Categories Financial Performance - The company anticipates a net profit attributable to shareholders of the parent company between 24 million to 28 million yuan for the first half of 2025 [1] Revenue Drivers - Key factors contributing to the profit increase include higher production and sales volumes, as well as revenue growth from main products [1] - The gross margin for olefins and coke has improved, further supporting the profit growth [1] Cost Management - A reduction in financial expenses has positively impacted the net profit [1] - Increased investment income has also contributed to the overall profit growth [1]

朋友们，今天市场上最靓的仔非券商和稀土莫属，尤其是香港券商ETF大涨近5%。 实际上，上午指数表现更夸张，银行保险这段时间直接把指数干到3500以上了，上证指数今 天上午也是直接高开高走打到3550，然后午后银行集体放量跳水，带动指数大回调，但大家 能看到，银行跳水队对整体市场影响并不大。 究其原因，大概可以找到两个线索， 第一是上证50的控制节奏，第二是中报业绩线定价开始 了！ 先说GJD控盘上证50的情况。 午后的银行跳水该怎么看？ 其实更多体现了GJD对指数的控盘能力非常好，为什么这么讲？ 那怎么看银行的快速下跌呢？ 第一明显这是资金在进行高低切换 ，获利资金从高位出逃，转向了低位品种。就像我们之前提 到的科创 50 指数，今天涨幅较强，显然有资金在介入！甚至之前大家不怎么待见的白酒公 司，也是出现了连续的底部反弹，资金往低位安全地带去的更多。 第二是调整节奏是有限的 ，因为这个是调控【节奏】，而不是调控【方向】，GJD肯定会保证 指数整体稳健，然后让市场在这个过程中慢慢往上挪，毕竟任何政策、任何利好，都不能一习 性打完，指数的节奏需要跟着后面政策思路慢慢往上挪，比如7月底的ZZJ会议，最近传的地 产刺 ...

Core Viewpoint - Limin Co., Ltd. plans to reduce its shareholding by up to 13.1 million shares, accounting for 3% of its total equity, primarily to meet financing repayment needs, despite recent performance improvements in the company [1][2]. Group 1: Shareholding Reduction - The controlling shareholder, Li Ming, intends to reduce his stake through block trading and centralized bidding within 90 days after 15 trading days from the announcement date [1]. - The planned reduction will yield approximately 265 million yuan based on the closing price of 20.20 yuan per share on July 10 [1]. - Three senior executives also disclosed their plans to reduce their holdings, totaling 296,000 shares, for similar financing repayment reasons [1]. Group 2: Financial Performance - Limin Co., Ltd. has experienced a decline in net profit over the past three years, with figures of 307 million yuan, 219 million yuan, and 62.05 million yuan, reflecting year-on-year decreases of 20.49%, 28.63%, and 71.67% respectively [2]. - In 2024, the company reported a revenue of 4.237 billion yuan, a slight increase of 0.32%, and a net profit of 81.36 million yuan, marking a year-on-year growth of 31.11% [2]. - The first quarter of 2024 showed a significant turnaround with revenues of 1.211 billion yuan, up 22.28%, and a net profit of 108 million yuan, compared to a loss of 8.49 million yuan in the same period last year [2]. Group 3: Market Dynamics and Strategy - The company's strong performance in Q1 2024 is attributed to high demand for its leading products, particularly due to the outbreak of soybean rust in Brazil and low inventory levels [3]. - Price increases for key products like Mancozeb and Abamectin are driven by supply constraints and rising demand [3]. - Limin Co., Ltd. plans to enhance its formulation R&D, focus on international market expansion, and optimize asset structure through various capital operations, including mergers and acquisitions [3].

Core Viewpoint - The article emphasizes the continuous improvement and advancement of the investment research system at Fuqun Fund, highlighting its strong performance in equity investment and the growing demand for stable mid-to-long-term investment products in the Chinese market [1][4][6]. Group 1: Market Context - As Chinese residents' wealth continues to grow, the demand for asset allocation is increasing, making public funds an important part of investment choices [3]. - Investors are increasingly focused on long-term performance rather than just short-term results, leading to a more rigorous evaluation of fund performance [3]. Group 2: Fuqun Fund's Performance - Fuqun Fund's active equity funds have demonstrated excellent investment capabilities, with a 20-year return of 953.86%, ranking 4th in the industry [6]. - As of June 30, 2025, 11 of Fuqun Fund's equity funds ranked in the top 10 of their categories for the past year, with several funds achieving returns exceeding 40% [8]. Group 3: Specific Fund Highlights - Fuqun Medical Innovation Stock A achieved a return of 58.87% over the past year, ranking 2nd among 45 funds in the medical and healthcare sector [8]. - Fuqun Consumption Select 30 Stock A has performed well in the new consumption investment trend, ranking 2nd among 38 funds in the consumption sector over the past year [8]. Group 4: Fixed Income and Hybrid Products - Fuqun Fund's fixed income products have shown strong performance, with Fuqun Strong Return Bond A achieving returns of 13.03%, 23.28%, and 45.09% over the past three, five, and seven years, respectively, ranking in the top 9 of its category [10]. - The "fixed income + equity" products, such as Fuqun Enhanced Bond and Fuqun Jiuli Stable Allocation Mixed A, have also performed well, with returns of 28.74% and 41.24% over the past year, ranking first in their categories [11]. Group 5: Quantitative Investment - Fuqun Fund's quantitative products have consistently ranked well, with 10 quantitative funds placing in the top 10 of their categories over the past year [12]. - The classic ETF, Fuqun Shanghai Composite Index ETF, has also performed well, ranking among the top five in its category over the past three, five, and seven years [12].